Agios Pharmaceuticals (AGIO) Preferred Dividend Payments (2012 - 2013)
Agios Pharmaceuticals' (AGIO) quarterly Preferred Dividend Payments came in at $567000.0 in Q3 2013, up 131.54% YoY from $244887.3 in Q3 2012, and down 68.46% on a QoQ basis from $1.8 million in Q2 2013.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
Agios Pharmaceuticals (AGIO) has 2 years of Preferred Dividend Payments data on file, last reported at $567000.0 in Q3 2013.
- Quarterly Preferred Dividend Payments rose 131.54% year-over-year to $567000.0 in Q3 2013, while the trailing twelve-month figure through Dec 2013 was $4.2 million (changed N/A YoY) and the FY2013 annual result came in at $4.2 million, down 42.11% from the prior year.
- Preferred Dividend Payments fell to $567000.0 in Q3 2013, from $1.8 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $12.6 million in Q4 2012 to a low of -$1.8 million in Q3 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Agios Pharmaceuticals | 1.97 Bn | 1.97 Bn | 41.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2013 | 567,000.00 |
| Jun 30, 2013 | 1.80 Mn |
| Mar 31, 2013 | 1.80 Mn |
| Dec 31, 2012 | 12.58 Mn |
| Sep 30, 2012 | -1.80 Mn |
| Jun 30, 2012 | 1.80 Mn |